FDA adds four tropical diseases to Priority Review voucher program

Compounds for four additional tropical diseases are now eligible to receive Priority Review vouchers upon FDA approval. FDA

Read the full 187 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE